| 发明名称 |
VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION |
| 摘要 |
<p>The present invention provides novel pharmaceutical agents and methods for treating or preventing diseases caused by neovascularization in human choroid (neovascular maculopathy). The present invention provides pharmaceutical compositions and vaccines for treating and/or preventing diseases caused by neovascularization in human choroid (neovascular maculopathy), comprising at least one type each of a peptide comprising an amino acid sequence derived from a VEGFR-1 protein and having an activity of inducing cytotoxic T cells, and a peptide comprising an amino acid sequence derived from a VEGFR-2 protein and having an activity of inducing cytotoxic T cells.</p> |
| 申请公布号 |
CA2764562(A1) |
申请公布日期 |
2010.12.16 |
| 申请号 |
CA20102764562 |
申请日期 |
2010.06.10 |
| 申请人 |
ONCOTHERAPY SCIENCE, INC. |
发明人 |
TSUJIKAWA, MOTOKAZU;NAKAMURA, YUSUKE;TSUNODA, TAKUYA |
| 分类号 |
A61K38/00;A61K39/00;A61P9/00;A61P27/02;A61P35/00;C07K14/71;C12N15/09 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
